CVE & CISA-KEV Catalog

CVE-2025-61940

HIGH
8.3
CVSS v3
NVD

Description

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.

CVSS v3 Vector

Exploitability

Attack VectorNetwork
Attack ComplexityLow
Privileges RequiredLow
User InteractionNone
ScopeUnchanged

Impact

ConfidentialityHigh
IntegrityHigh
AvailabilityLow

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L

Exploit Intelligence

0.29%probability of exploitation in 30 days
20thpercentile

Low risk: more likely to be exploited than 20% of all known CVEs.

References

Find and fix vulnerabilities across your fleet

TridentStack Control continuously scans your Windows, macOS, and Linux fleet for known vulnerabilities, prioritizes them by severity and active exploitation, and patches them automatically.

Start free

This product uses NVD data but is not endorsed or certified by the NVD. EPSS scores courtesy of FIRST.org (https://www.first.org/epss). Source: CISA KEV Catalog. Data as of 2026-01-02.